The Lancet Assesses The Five Candidates Running For The Next Executive Director Of The Global Fund
Main Category: HIV / AIDSAlso Included In: Infectious Diseases / Bacteria / Viruses; Respiratory / Asthma; Tropical Diseases
Article Date: 31 Oct 2006 - 10:00 PDT
| Patient / Public: | ![]() |
5 (1 votes) |
| Healthcare Prof: | ![]() |
Three of the five candidates running for the job of the next Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria lead the field, with the edge going to one, according to an Editorial in this week's issue of The Lancet.
On Nov 1, the next Executive Director of the Global Fund will be announced. The five candidates are: Hilde Johnson, senior adviser to the President of the African Development Bank; Michel Kazatchkine, France's ambassador against HIV/AIDS and communicable diseases; Jim Kolbe, a Republican Congressman for Arizona; Bill Roedy, Vice Chairman of MTV Networks and President of MTV Networks International and an ambassador for UNAIDS; and Michel Sidibe, Director of the Country and Regional Support Department at UNAIDS.
In the Editorial, The Lancet assesses each candidate and comments: "The key criteria for this post are to optimise the Global Fund's grant performance, to accelerate results, and to mobilise resources, including getting donors to honour their pledges. Most importantly, the appointee needs to understand the importance of evaluation, and to break down the dependencies that can arise from being a donor or a recipient, ensuring that the relationship is one of true partnership. From the five candidates, Johnson, Kazatchkine, and Sidibe lead the field, with the edge going to Sidibe because of his strong first-hand experience of Africa."
###
Contact: Lancet press office
Lancet
Visit our hiv / aids section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/55292.php>
APA
http://www.medicalnewstoday.com/releases/55292.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




